Knowledge about cervical cancer early warning signs and symptoms, risk factors and vaccination among students at a medical school in Al-Ahsa, Kingdom of Saudi Arabia

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 6, 2014, Pages 2529-2532

  Al Darwish, Abdulaziz Ahmed ^a   Al Naim, Abdullah Fouad ^a   Al Mulhim, Khalid Saleh ^a   Al Otaibi, Nasser Khaled ^a   Morsi, Mohammed Saad ^a   Aleem, Ansari Mukhtar ^a  

^a KING FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Cervical cancer; HPV vaccine; Kingdom of saudi arabia; Knowledge; Medical students

Indexed keywords

WART VIRUS VACCINE;

ATTITUDE TO HEALTH; AWARENESS; CROSS-SECTIONAL STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; MEDICAL STUDENT; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTIONS; PHYSIOLOGY; PREVENTIVE HEALTH SERVICE; PROGNOSIS; PSYCHOLOGY; QUESTIONNAIRE; RISK FACTOR; SAUDI ARABIA; STATISTICS AND NUMERICAL DATA; TIME; UTERINE CERVICAL NEOPLASMS; VACCINATION; VIROLOGY;

AWARENESS; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; IMMUNIZATION PROGRAMS; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PROGNOSIS; QUESTIONNAIRES; RISK FACTORS; SAUDI ARABIA; STUDENTS, MEDICAL; TIME FACTORS; UTERINE CERVICAL NEOPLASMS; VACCINATION;

EID: 84899816465     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.6.2529     Document Type: Article

References (26)

1. Al-Naggar RA, Isa ZM (2010). Perception and opinion of medical students about Pap smear test: a qualitative study. Asian Pac J Cancer Prev, 11, 435-40.
2. Arbyn M, Castellsague X, de Sanjose S, et al (2011). Worldwide burden of cervical cancer in 2008. Ann Oncol, 22, 2675-86.
3. Berraho M, Fakir SE, Abda N, et al (2013). HPV and cervical cancer: knowledge and practices of physicians in Fez. Sante Publique, 25, 351-7.
4. Bosch FX, Lorincz A, Munoz N, et al (2002). The causal relation between human papillomavirus and cervical cancer. J Clin Pathol, 55, 244-65.
5. Donders GG, Gabrovska M, Bellen G, et al (2008). Knowledge of cervix cancer, human papilloma virus (HPV) and HPV vaccination at the moment of introduction of the vaccine in women in Belgium. Arch Gynecol Obstet, 277, 291-8.
6. Dursun P, Altuntas B, Kuscu E, Ayhan A (2009). Women's knowledge about human papillomavirus and their acceptance of HPV vaccine. Aust N Z J Obstet Gynaecol, 49, 202-6.
7. Harper DM, Franco EL, Wheeler CM, et al (2006). HPV Vaccine Study group. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomized control trial. Lancet, 367, 1247-55.
8. Ilter E, Celik A, Haliloglu B, et al (2010). Women's knowledge of Pap smear test and human papillomavirus acceptance of HPV vaccination to themselves and their daughters in an Islamic society. Int J Gynecol Cancer, 20, 1058-62.
9. Khan S, Jaffer NN, Khan MN, et al (2007). Human papillomavirus subtype 16 is common in Pakistaniwomen with cervical carcinoma. Int J Infect Dis, 11, 313-17.
10. Manji M (2000). Cervical cancer screening program in Saudi Arabia: action is overdue. Ann Saudi Med, 20, 355-7.
11. Makoha FW, Raheem MA (2008). Gynecological cancer incidence in a hospital population in Saudi Arabia: the effect of foreign immigration over two decades. J Obstet Gynaecol Res, 34, 538-42.
12. McCusker SM, Macqueen I, Lough G, et al (2013). Gaps in detailed knowledge of human papillomavirus (HPV) and the HPV vaccine among medical students in Scotland. BMC Public Health, 13, 264.
13. Munoz N, Bosch FX, de Sanjose S, et al (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med, 348, 518-27.
14. Mutyaba T, Mmiro FA, Weiderpass E (2006). Knowledge, attitudes and practices on cervical cancer screening among the medical workers of Mulago Hospital, Uganda. BMC Med Educ, 1, 6-13.
15. Newman PA, Logie CH, Doukas N, et al (2013). HPV vaccine acceptability among men: a systematic review and meta-analysis. Sex Transm Infect, 89, 568-74.
16. Ortashi O, Raheel H, Shalal M, Osman N, et al (2013). Awareness and knowledge about human papillomavirus infection and vaccination among women in UAE. Asian Pac J Cancer Prev, 14, 6077-80.
17. Pandey D, Vanya V, Bhagat S, et al (2012). Awareness and attitude towards human papillomavirus (HPV) vaccine among medical students in a premier medical school in India. PLoS One, 7, 40619.
18. Rashwan HH, Saat NZ, Abd Manan DN (2012). Knowledge, attitude and practice of Malaysian medical and pharmacy students towards human papillomavirus vaccination. Asian Pac J Cancer Prev, 13, 2279-83
19. Roteli-Martins C, Naud P, de Borba P, et al (2012). Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine: up to 8.4 years of follow-up. Hum Vaccine Immunother, 8, 390-97.
20. Sait KH (2009), Attitudes, knowledge, and practices in relation to cervical cancer and its screening among women in Saudi Arabia. Saudi Med J, 30, 1208-12.
21. Stanley M (2010). Pathology and epidemiology of HPV infection in females. Gynecol Oncol, 117, 5-10.
22. Teresa J, Brijesh S, Chacchu B, et al (2011). Awareness of cervix cancer risk factors in educated youth: A cross-sectional, questionnaire based survey in India, Nepal, and Sri Lanka. Asian Pacific J Cancer Prev, 12, 1707-12.
23. The Future II Study Group (2007). Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med, 356, 1915-27.
24. Villa LL, Costa RL, Petta CA, et al (2005). Prophylactic quadrivalent human papillomavirus (types 6, 11, 16 & 18) L1 virus-like particle vaccine in young women: a randomized double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol, 6, 271-78.
25. Walboomers JM, Jacobs MV, Manos MM, et al (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189, 12-9.
26. Zhao FH, Tiggelaar SM, Hu SY, et al (2012). A multi-center survey of HPV knowledge and attitudes toward HPV vaccination among women, government officials, and medical personnel in China. Asian Pac J Cancer Prev, 13, 2369-78.